R. Williams

First name
R.
Last name
Williams
Strongman, H., Christopher, S., Majak, M., Williams, R., Bahmanyar, S., Linder, M., et al. (2018). Pioglitazone and cause-specific risk of mortality in patients with type 2 diabetes: extended analysis from a European multidatabase cohort study. BMJ Open Diabetes Res Care. http://doi.org/10.1136/bmjdrc-2017-000481
Ride, J., Kasteridis, P., Gutacker, N., Kronenberg, C., Doran, T., Mason, A., et al. (2018). Do care plans and annual reviews of physical health influence unplanned hospital utilisation for people with serious mental illness? Analysis of linked longitudinal primary and secondary healthcare records in England. BMJ Open. http://doi.org/10.1136/bmjopen-2018-023135
Williams, R., van Staa, T. P., Gallagher, A. M., Hammad, T., Leufkens, H. G. M., & de Vries, F. (2018). Cancer recording in patients with and without type 2 diabetes in the Clinical Practice Research Datalink primary care data and linked hospital admission data: a cohort study. BMJ Open. http://doi.org/10.1136/bmjopen-2017-020827
Padmanabhan, S., Carty, L., Cameron, E., Ghosh, R. E., Williams, R., & Strongman, H. (2018). Approach to record linkage of primary care data from Clinical Practice Research Datalink to other health-related patient data: overview and implications. Eur J Epidemiol. http://doi.org/10.1007/s10654-018-0442-4
Williams, R., Kothny, W., Serban, C., Lopez-Leon, S., & Schlienger, R. (2019). Pancreatic safety of vildagliptin in patients with type 2 diabetes mellitus: A European, noninterventional, postauthorization safety study. Endocrinol Diabetes Metab. http://doi.org/10.1002/edm2.52
Gieling, E., de Vries, F., Williams, R., van Onzenoort, H. A. W., de Boer, A., Cate, T., et al. (2019). Mortality risk in atrial fibrillation: the role of aspirin, vitamin K and non-vitamin K antagonists. Int J Clin Pharm. http://doi.org/10.1007/s11096-019-00916-1
Minassian, C., Williams, R., Meeraus, W. H., Smeeth, L., Campbell, O. M. R., & Thomas, S. L. (2019). Methods to generate and validate a Pregnancy Register in the UK Clinical Practice Research Datalink primary care database. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.4811
Strongman, H., Williams, R., Meeraus, W., Murray-Thomas, T., Campbell, J., Carty, L., et al. (2019). Limitations for health research with restricted data collection from UK primary care. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.4765
Ghosh, R. E., Crellin, E., Beatty, S., Donegan, K., Myles, P., & Williams, R. (2019). How Clinical Practice Research Datalink data are used to support pharmacovigilance. Therapeutic Advances in Drug Safety. http://doi.org/10.1177/2042098619854010
Carreira, H., Williams, R., Strongman, H., & Bhaskaran, K. (2019). Identification of mental health and quality of life outcomes in primary care databases in the UK: a systematic review. BMJ Open. http://doi.org/10.1136/bmjopen-2019-029227